LON:MHN - Menhaden Capital Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
GBX 0.71 -0.22 (-23.59 %)
(As of 07/22/2018 04:00 PM ET)
Previous CloseGBX 0.71
Today's RangeGBX 0.71 - GBX 0.71
52-Week RangeGBX 59 - GBX 71
Volume172 shs
Average Volume50,865 shs
Market Capitalization£56.01 million
P/E RatioN/A
Dividend YieldN/A
The Company's investment objective is to generate long-term Shareholder returns, predominantly in the form of capital growth, by investing in businesses and opportunities, irrespective of their size, location or stage of development, delivering or benefiting from the efficient use of energy and resources.

Receive MHN News and Ratings via Email

Sign-up to receive the latest news and ratings for MHN and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange LON
Industry N/A


Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A


Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A


EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins68.42%
Return on Equity5.21%
Return on Assets5.20%


Outstanding Shares80,000,000
Market Cap£56.01

Menhaden Capital (LON:MHN) Frequently Asked Questions

What is Menhaden Capital's stock symbol?

Menhaden Capital trades on the London Stock Exchange (LON) under the ticker symbol "MHN."

What is the consensus analysts' recommendation for Menhaden Capital?

0 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Menhaden Capital in the last year. There are currently for the stock, resulting in a consensus recommendation of "N/A."

Who are Menhaden Capital's key executives?

Menhaden Capital's management team includes the folowing people:
  • Ian Cheshire, Chairman of the Board (Age 57)
  • Emma Howard Boyd, Non-Executive Director
  • Duncan W. A. Budge, Non-Executive Director (Age 61)
  • Howard Pearce, Non-Executive Director

Has Menhaden Capital been receiving favorable news coverage?

Headlines about MHN stock have trended somewhat positive on Sunday, according to Accern Sentiment Analysis. The research firm identifies positive and negative media coverage by monitoring more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Menhaden Capital earned a media sentiment score of 0.14 on Accern's scale. They also assigned news coverage about the company an impact score of 45.61 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company's share price in the near term.

How do I buy shares of Menhaden Capital?

Shares of MHN and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Menhaden Capital's stock price today?

One share of MHN stock can currently be purchased for approximately GBX 0.71.

How big of a company is Menhaden Capital?

Menhaden Capital has a market capitalization of £56.01 million.

MarketBeat Community Rating for Menhaden Capital (LON MHN)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  35 (Vote Outperform)
Underperform Votes:  32 (Vote Underperform)
Total Votes:  67
MarketBeat's community ratings are surveys of what our community members think about Menhaden Capital and other stocks. Vote "Outperform" if you believe MHN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MHN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/22/2018 by MarketBeat.com Staff

Featured Article: Analyst Ratings

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.